University of California San Francisco

News & Events

Displaying 1 - 16 of 16
Chancellor Awards for Diversity

Department of Surgery staff and faculty receive 2022 Chancellor Awards for Diversity

UCSF Department of Surgery
October 27, 2022
UCSF and the Department and Surgery are committed to building a broadly diverse community, nurturing a culture that is welcoming and supportive, and engaging diverse ideas for the provision of culturally competent education, discovery, and patient care. Chancellor Awards for Diversity Chancellor Awards for...
Simone Natalya Thorson Kurial Bsc

Simone received Lloyd M. Kozloff Fellowship

Willenbring Lab
June 08, 2020
The Lloyd M. Kozloff Fellowship rewards excellence in research. Prior academic achievements and potential for future contributions to the health sciences also are considered.
Fengchen

Feng received Liver Center Pilot/Feasibility Grant

Willenbring Lab
June 01, 2020
The Pilot/Feasibility Award Program provides seed money to investigators who are attempting to launch new liver-related research projects. The program supports both clinical and basic research relevant to the liver. The goal of the program is to enable investigators to test new hypotheses and obtain preliminary...
Holger Willenbring, MD, PhD 354x210

Holger Willenbring Receives Discovery Stage Research Projects Award from CIRM

Willenbring Lab
July 08, 2017
Holger Willenbring, MD, PhD is the receipient of a Discovery Stage Research Project award from the California Institute for Regenerative Medicine (CIRM). The project " Preclinical development of AAV vector-mediated in vivo hepatic reprogramming of myofibroblasts as a therapy for liver fibrosis" was approved for $1...

NIH Awards Department of Surgery T32 Training Grant for Transplant Surgery

UCSF Department of Surgery
January 06, 2017
The NIH has awarded the UCSF Department of Surgery a T32 training grant , “Filling a Void of Research Training for Transplant Surgeons” (FAVOR). The grant, awarded in August 2016, provides annual funding in the amount of $156,602 for in-depth training of three general surgery residents with an interest in...

Researchers Convert Cirrhosis-Causing Cells to Healthy Liver Cells in Mice

Willenbring Lab
June 03, 2016
UCSF News reports on the research of the Willenbring Lab and others demonstrating in mice that healthy new liver cells could be generated within the organ itself, thus making engraftment unnecessary. The article noted that the very cells that drive liver disease were converted, thereby reducing liver damage and...

Garrett Roll Joins Division of Transplant Surgery

UCSF Transplant Surgery
October 16, 2015
The UCSF Division of Transplant Surgery is pleased to announce that Garrett R. Roll, M.D., FACS, recently joined the division as Assistant Professor Of Clinical Surgery. Dr. Roll is a transplant surgeon specializing in kidney, liver and pancreas transplantation, and in hepatobiliary surgery. Dr. Roll attended...

Scientists Transform Skin Cells into Functioning Liver Cells

Willenbring Lab
February 23, 2014
A recent paper in the journal Nature, reported by UCSF News by a research team including Associate Professor Holger Willenbring, M.D., Ph.D. and Senior Resident Jack Harbell, M.D., a former postdoctoral fellow in the Willenbring lab, reports a new method of cellular reprogramming with potential for treating liver...

Deadly Liver Cancer May Be Triggered by Cells Changing Identity, UCSF Study Shows

Willenbring Lab
July 16, 2012
Intrahepatic bile duct cancer, a rare and deadly form of cancer, known formally as cholangiocarcinoma, has been assumed to derive from cells in the bile ducts of the liver. However, a n international team, led by Holger F. Willenbring, M.D., Ph.D., Associate Professor of Developmental and Stem Cell Biology in the...

Rescuing Liver Function in Patients at Risk of Liver Failure

Willenbring Lab
October 22, 2010
UCSF scientists have received two large grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure. A team led by Mark Zern, MD, of the University of California, Davis, and including co-principal...